| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |